BrilliantStrings Therapeutics

Healing with Complete
Human Collagen (CHC™)

Our mechanotherapeutic platform revolutionizes the way connective tissues repair and restore.

A Next Generation Approach To Healing

We offer a next-generation collagen platform that enables precise, injectable delivery of complete human collagen—advancing beyond first-generation therapeutics to enable rapid, effective healing. Our proprietary manufacturing and targeting approach represents a breakthrough in musculoskeletal injury treatment and wound repair.

Scientific Foundation

Built on decades of research in extracellular matrix mechanochemistry and collagen assembly.

Therapeutic Breakthrough

CHC™ is a mechano-therapeutic capable of rapidly repairing injured or degenerated connective tissue.

Targeted Delivery

A proprietary, densly packed, liquid-crystal delivery system protects and precisely delivers CHC™ to the injury site.

Injectable Therapeutic

To treat rotator cuff and tendon injuries prior to requiring surgery, BrilliantStrings is developing the first injectable Complete Human Collagen system. Delivered under ultrasound guidance, the dense collagen solution homes to the injury and supports tendon repair through controlled release.

Our Team

Jeff Ruberti, PhD

CEO & Founder

Martha Shadan, MBA

Board Chairwoman

Luke Oh, MD

Scientific Advisory Chair

Scott Weiss, MBA

Chief of Operations

Fueling Our Mission

Learn more about our technology as we finalize our product profile, scale collagen production, and launch Phase I trials.

Get In Touch